RecruitingNot ApplicableNCT07486791

A Clinical Study on the Effect of Cardiopulmonary Function and Quality of Life in Patients With Acute Coronary Syndrome Complicated by Heart Failure by "Lying-Sitting-Standing" Sequential Baduanjin

Sponsor

Xiling Qi

Enrollment

65 participants

Start Date

Mar 10, 2026

Study Type

INTERVENTIONAL

Conditions

ACS (Acute Coronary Syndrome)HF - Heart Failure

Summary

This study investigates the effects of a sequential "lying-sitting-standing" Baduanjin intervention on patients with acute coronary syndrome complicated by heart failure. By evaluating cardiopulmonary function and quality of life through indicators such as echocardiography, NT-proBNP, 6MWT, NYHA classification, and SF-36, we aim to compare its efficacy with conventional treatment. The objective is to provide new insights for early cardiac rehabilitation strategies in patients with acute coronary syndrome complicated by heart failure

Eligibility

Max Age: 85 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a behavioral approach called "Lying-Sitting-Standing" Sequential Baduanjin and a behavioral approach called standard treatment and routine rehabilitation nursing guidance for people with acs (acute coronary syndrome) and hf - heart failure. The study is currently recruiting participants at 1 location. People eligible for this study include up to age 85 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.